This inventor holds 2 USPTO granted patents. Top assignees: Neoprobe Corporation, The Ohio State University. Active years: 1998-2000.
Company Filing History:
Years Active: 1998-2000
Title: Innovations in Cancer Treatment by Julian A Kim
Introduction
Julian A Kim is a notable inventor based in Columbus, OH, who has made significant contributions to the field of cancer treatment. With a focus on improving the efficacy of chemotherapy, he has developed innovative methods that enhance patient outcomes. His work is characterized by a commitment to advancing medical science through targeted therapies.
Latest Patents
Julian A Kim holds 2 patents that reflect his dedication to cancer research. His latest patents include a method for modulating the sensitivity of tumor cells to chemotherapeutics. This invention discloses a technique for improving the treatment of cancer patients undergoing adjuvant chemotherapy. The method involves administering mitogenically stimulated lymph node lymphocytes or their supernatant to patients prior to or during chemotherapy. Additionally, he has developed a method for reliably determining lymph nodes enriched in tumor-reactive cells. This process utilizes radiolabeled locators to identify lymph nodes that may contain tumor-specific lymphocytes, allowing for targeted treatment.
Career Highlights
Throughout his career, Julian A Kim has worked with esteemed organizations such as The Ohio State University and Neoprobe Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in oncology.
Collaborations
Julian A Kim has collaborated with notable professionals, including Pierre L Triozzi and Edward W Martin. These partnerships have facilitated the exchange of ideas and fostered advancements in cancer treatment methodologies.
Conclusion
Julian A Kim's innovative approaches to cancer treatment exemplify the potential of targeted therapies in improving patient care. His contributions to the field are invaluable and continue to inspire future research and development in oncology.